Display options
Share it on

Front Neurol. 2019 Jan 17;9:1199. doi: 10.3389/fneur.2018.01199. eCollection 2018.

ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas.

Frontiers in neurology

Lincoln A Edwards, Sungjin Kim, Mecca Madany, Miriam Nuno, Tom Thomas, Aiguo Li, Dror Berel, Bong-Sup Lee, Minzhi Liu, Keith L Black, Xuemo Fan, Wei Zhang, John S Yu

Affiliations

  1. Neurosurgery Department, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  2. Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  3. Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.
  4. Pathology and Laboratory Medicine Department, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

PMID: 30705664 PMCID: PMC6345215 DOI: 10.3389/fneur.2018.01199

[No abstract available.]

Keywords: ZEB1; copy number; decision curve analysis; diffuse gliomas; glioma stem cells (GSCs)

References

  1. Nature. 2004 Nov 18;432(7015):396-401 - PubMed
  2. Oncogene. 2004 Dec 16;23(58):9392-400 - PubMed
  3. Hum Mol Genet. 2005 Nov 15;14(22):3361-70 - PubMed
  4. Cancer Cell. 2006 May;9(5):391-403 - PubMed
  5. Nature. 2006 Dec 7;444(7120):756-60 - PubMed
  6. Cell Mol Life Sci. 2009 Mar;66(5):773-87 - PubMed
  7. BMC Med Inform Decis Mak. 2008 Nov 26;8:53 - PubMed
  8. N Engl J Med. 2009 Feb 19;360(8):765-73 - PubMed
  9. Cancer Cell. 2009 Apr 7;15(4):315-27 - PubMed
  10. Nat Cell Biol. 2009 Dec;11(12):1487-95 - PubMed
  11. Epidemiology. 2010 Jan;21(1):128-38 - PubMed
  12. Acta Neuropathol. 2010 Sep;120(3):297-304 - PubMed
  13. EMBO J. 2011 Feb 16;30(4):770-82 - PubMed
  14. J Natl Cancer Inst. 2011 Aug 3;103(15):1162-78 - PubMed
  15. Cancer Discov. 2012 May;2(5):401-4 - PubMed
  16. PLoS One. 2012;7(5):e36944 - PubMed
  17. J Clin Oncol. 2012 Sep 1;30(25):3065-70 - PubMed
  18. J Clin Oncol. 2013 Jan 20;31(3):344-50 - PubMed
  19. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5 - PubMed
  20. EMBO Mol Med. 2013 Aug;5(8):1196-212 - PubMed
  21. Cell. 2013 Jul 3;154(1):61-74 - PubMed
  22. Neuro Oncol. 2013 Nov;15 Suppl 2:ii1-56 - PubMed
  23. Brain Pathol. 2015 Nov;25(6):724-32 - PubMed
  24. Nat Genet. 2015 May;47(5):458-68 - PubMed
  25. BMC Bioinformatics. 2015 Apr 28;16:131 - PubMed
  26. N Engl J Med. 2015 Jun 25;372(26):2481-98 - PubMed
  27. N Engl J Med. 2015 Jun 25;372(26):2499-508 - PubMed
  28. Eur J Hum Genet. 2016 Jul;24(7):985-91 - PubMed
  29. N Engl J Med. 2016 Apr 7;374(14):1344-55 - PubMed
  30. Acta Neuropathol. 2016 Jun;131(6):803-20 - PubMed
  31. Nat Commun. 2016 Jul 26;7:12231 - PubMed
  32. J Neurooncol. 2016 Oct;130(1):111-122 - PubMed
  33. Eur Rev Med Pharmacol Sci. 2016 Aug;20(16):3385-91 - PubMed
  34. Sci Rep. 2017 Dec;7(1):69 - PubMed
  35. Biomed Pharmacother. 2018 Mar;99:72-80 - PubMed
  36. Am J Transl Res. 2018 Feb 15;10(2):605-617 - PubMed
  37. Stat Med. 1996 Feb 28;15(4):361-87 - PubMed
  38. Cancer. 1997 Apr 1;79(7):1381-93 - PubMed
  39. J Immunol. 1998 May 1;160(9):4433-40 - PubMed

Publication Types

Grant support